AURA
Price
$6.88
Change
-$0.01 (-0.14%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
743.35M
64 days until earnings call
Intraday BUY SELL Signals
CADL
Price
$8.79
Change
+$0.37 (+4.39%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
617.67M
77 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AURA vs CADL

Header iconAURA vs CADL Comparison
Open Charts AURA vs CADLBanner chart's image
AURA vs CADL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AURA vs. CADL commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Buy and CADL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (AURA: $6.91 vs. CADL: $8.43)
Brand notoriety: AURA and CADL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 86% vs. CADL: 89%
Market capitalization -- AURA: $743.35M vs. CADL: $617.67M
AURA [@Biotechnology] is valued at $743.35M. CADL’s [@Biotechnology] market capitalization is $617.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileCADL’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • CADL’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 4 TA indicator(s) are bullish while CADL’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 4 bullish, 5 bearish.
  • CADL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both AURA and CADL are a bad buy in the short-term.

Price Growth

AURA (@Biotechnology) experienced а -9.26% price change this week, while CADL (@Biotechnology) price change was +6.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

AURA is expected to report earnings on Aug 06, 2026.

CADL is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($743M) has a higher market cap than CADL($618M). CADL YTD gains are higher at: 49.204 vs. AURA (26.697). CADL has higher annual earnings (EBITDA): -50.3M vs. AURA (-117.51M). CADL has more cash in the bank: 195M vs. AURA (115M). AURA has less debt than CADL: AURA (17M) vs CADL (49.3M). AURA (0) and CADL (0) have equivalent revenues.
AURACADLAURA / CADL
Capitalization743M618M120%
EBITDA-117.51M-50.3M234%
Gain YTD26.69749.20454%
P/E RatioN/AN/A-
Revenue00-
Total Cash115M195M59%
Total Debt17M49.3M34%
TECHNICAL ANALYSIS
Technical Analysis
AURACADL
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signal:
Gain/Loss:
CADL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICIEX24.40N/A
N/A
Nomura Core Equity Fund Class I
MEICX50.74N/A
N/A
MFS Value C
GSXPX70.41N/A
N/A
Goldman Sachs Small Cp Val Insghts P
MCECX21.28N/A
N/A
ClearBridge Emerging Markets C
BIAYX12.07N/A
N/A
Brown Advisory Sustainable Sml-Cp Cr Inv

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with AURA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-0.94%
AURA - CADL
47%
Loosely correlated
-3.96%
RXRX - CADL
43%
Loosely correlated
-4.62%
CRBU - CADL
43%
Loosely correlated
-4.32%
MGX - CADL
41%
Loosely correlated
+1.53%
NKTX - CADL
40%
Loosely correlated
-7.32%
More